We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current REGN34 market cap is 7.88B. The company's latest EPS is USD 36.9050 and P/E is 19.42.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.36B | 3.43B | 3.15B | 3.55B | 3.72B |
| Operating Income | 1.11B | 972.9M | 751.4M | 1.07B | 1.18B |
| Net Income | 1.01B | 1.16B | 722M | 1.43B | 1.34B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.86B | 8.78B | 16.12B | 12.26B | 13.12B |
| Operating Income | 2.21B | 3.58B | 8.95B | 4.74B | 4.05B |
| Net Income | 2.12B | 3.51B | 8.08B | 4.34B | 3.95B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 32.16B | 33.08B | 34.37B | 36.09B | 37.44B |
| Total Liabilities | 7.26B | 7.11B | 7.38B | 7.88B | 8.12B |
| Total Equity | 24.9B | 25.97B | 26.99B | 28.21B | 29.33B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.81B | 17.16B | 25.43B | 29.21B | 33.08B |
| Total Liabilities | 3.72B | 6.14B | 6.67B | 6.55B | 7.11B |
| Total Equity | 11.09B | 11.03B | 18.77B | 22.66B | 25.97B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 3.5B | 4.59B | 1.51B | 1.87B | 3.16B |
| Investing | -3.12B | -3.19B | -1.69B | -2.24B | -2.82B |
| Financing | -1.34B | -1.79B | 47.1M | -431M | -1.07B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.43B | 2.62B | 7.08B | 5.01B | 4.59B |
| Investing | -2.03B | -70.6M | -5.38B | -3.78B | -3.19B |
| Financing | -252.1M | -1.97B | -1.01B | -1.01B | -1.79B |
| Market Cap | 7.88B |
| Price to Earnings Ratio | 19.42 |
| Price to Sales Ratio | 5.85 |
| Price to Cash Ratio | 28.12 |
| Price to Book Ratio | 2.96 |
| Dividend Yield | - |
| Shares Outstanding | 107.13M |
| Average Volume (1 week) | 67 |
| Average Volume (1 Month) | 591 |
| 52 Week Change | 7.98% |
| 52 Week High | 111.72 |
| 52 Week Low | 67.97 |
| Spread (Intraday) | 530 (88.33%) |
| Company Name | Regeneron Pharmaceuticals Inc |
| Address |
28 liberty street new york, new york 10005 |
| Website | https://www.regeneron.com |
| Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
